Patents-Review.com
ClassID:

20461 ⎘

A61K31/557 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients Eicosanoids, e.g. leukotrienes or prostaglandins

Sub-classes:
Recent Application in this class:
#1
20260060936
2026-03-05

INDOLIUM-BASED STABILIZERS OF HYDROPHOBIC DRUGS

 #2
20260048097
2026-02-19

DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION

 #3
20260041696
2026-02-12

IN-SITU PRODUCTION OF ANTI-INFLAMMATORY LIPIDS USING MILK FAT GLOBULES

 #4
20260007656
2026-01-08

METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, PNEUMONIA, BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, PULMONARY ARTERIAL HYPERTENSION, ADN RESPIRATORY SYNCYTIAL VIRUS

 #5
20250381199
2025-12-18

PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN

 #6
20250332175
2025-10-30

Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension

 #7
20250221849
2025-07-10

ANTERIOR SEGMENT DRUG DELIVERY

 #8
20250136987
2025-05-01

CHANNEL MODULATORS

 #9
20250090547
2025-03-20

EPA-EE LIPID NANOCOMPOSITE, FORMULATION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

 #10
20240358641
2024-10-31

PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE

 #11
20240277609
2024-08-22

INTRAOCULAR PRESSURE REDUCTION WITH INTRACAMERAL BIMATOPROST IMPLANTS

 #12
20240252513
2024-08-01

Oral Allopregnanolone Compositions and Methods of Use

 #13
20240173251
2024-05-30

BIO-ERODIBLE OCULAR IMPLANTS FOR TREATMENT OF CONDITIONS OF THE EYE

 #14
20240100003
2024-03-28

Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

 #15
20240082261
2024-03-14

COMPOSITIONS AND USES THEREOF FOR TREATMENT OF IDIOPATHIC PRETERM BIRTH

 #16
20230346799
2023-11-02

Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension

 #17
20230255944
2023-08-17

INHALABLE RAPAMYCIN FORMULATION FOR THE TREATMENT OF PULMONARY HYPERTENSION

 #18
20230255892
2023-08-17

OSMOTIC DRUG DELIVERY SYSTEM

 #19
20230248741
2023-08-10

Compositions and Methods for Lowering Triglycerides in a Subject with Reduced Kidney Function and Diabetes Mellitus

 #20
20230233687
2023-07-27

HYALURONIC ACID-BASED FORMULATIONS FOR TREATMENT AND PREVENTION OF OCULAR HYPERTENSION AND GLAUCOMA

 #21
20230218560
2023-07-13

COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A SURFACTANT, AND METHODS AND USES THEREOF

 #22
20230210930
2023-07-06

COMPOSITIONS AND METHODS FOR TREATING DEPRESSION

 #23
20230190821
2023-06-22

REGENERATIVE NONSTEROIDAL ANTI-INFLAMMATORY COMPOSITIONS, METHODS OF PRODUCTION, AND METHODS OF USE THEREOF

 #24
20230181675
2023-06-15

NOVEL FORMUATIONS

 #25
20230174980
2023-06-08

CHANNEL MODULATORS

 #26
20230165791
2023-06-01

DRUG DELIVERY METHODS, STRUCTURES, AND COMPOSITIONS FOR NASOLACRIMAL SYSTEM

 #27
20230158043
2023-05-25

PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN

 #28
20230149423
2023-05-18

COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS, 17-HDHA AND 18-HEPE AND METHODS OF USING SAME

 #29
20230149422
2023-05-18

COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS, 17-HDHA AND 18-HEPE AND METHODS OF USING SAME

 #30
20230112834
2023-04-13

PARENTERAL FORMULATIONS OF TREPROSTINIL

 #31
20230102547
2023-03-30

ANTERIOR SEGMENT DRUG DELIVERY

 #32
20230092870
2023-03-23

MARGARIC ACID DECREASES PIEZ02-MEDIATED PAIN

 #33
20230062605
2023-03-02

TREPROSTINIL ADMINISTRATION BY INHALATION

 #34
20230026451
2023-01-26

INTRAOCULAR PRESSURE REDUCTION WITH INTRACAMERAL BIMATOPROST IMPLANTS

 #35
20220387444
2022-12-08

COMPOSITION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND LATANOPROST

 #36
20220339237
2022-10-27

DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION

 #37
20220323459
2022-10-13

TREPROSTINIL ADMINISTRATION BY INHALATION

 #38
20220280466
2022-09-08

Memory in subjects with mini-mental state examination of 24-26

 #39
20220257608
2022-08-18

Dry powder treprostinil for the treatment of pulmonary hypertension

 #40
20220218720
2022-07-14

TREPROSTINIL ADMINISTRATION BY INHALATION

 #41
20220175711
2022-06-09

Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors

 #42
20220133668
2022-05-05

ISOTOPICALLY MODIFIED COMPONENTS AND THERAPEUTIC USES THEREOF

 #43
20220088032
2022-03-24

Compositions and uses thereof for treatment of idiopathic preterm birth

 #44
20220088000
2022-03-24

COMBINATION THERAPY

 #45
20220062210
2022-03-03

Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

 #46
20220008436
2022-01-13

Treprostinil administration by inhalation

 #47
20220008435
2022-01-13

Therapeutic, preventive, or improvement agent for inflammatory disease and allergic disease

 #48
20220008434
2022-01-13

Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same

 #49
20210401794
2021-12-30

Methods of Using Cannabinoid Compositions for Inducing and Promoting Sleep

 #50
20210379005
2021-12-09

Esters for treatment of ocular inflammatory conditions

 #51
20210353641
2021-11-18

Dry powder treprostinil for the treatment of pulmonary hypertension

 #52
20210353640
2021-11-18

Dry powder treprostinil for the treatment of pulmonary hypertension

 #53
20210322441
2021-10-21

CYSTEINYL-PRORESOLVING MEDIATORS THAT PROMOTE RESOLUTION OF INFECTION AND ORGAN PROTECTION

 #54
20210322318
2021-10-21

PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE

 #55
20210308087
2021-10-07

TREATMENT AND PREVENTION OF BONE LOSS USING RESOLVINS

 #56
20210308070
2021-10-07

TRANSDERMAL DELIVERY OF PHARMACEUTICAL AGENTS

 #57
20210275484
2021-09-09

Lipoxin and lipoxin analogue mediated neuroprotection and treatments

 #58
20210244722
2021-08-12

Compositions for treating glaucoma or reducing intraocular pressure

 #59
20210244697
2021-08-12

COMPOSITIONS COMPRISING 15-OHEPA AND METHODS OF USING THE SAME

 #60
20210236477
2021-08-05

Combination therapy

 #61
20210228524
2021-07-29

COMPOSITIONS COMPRISING 15-OHEPA AND METHODS OF USING THE SAME

 #62
20210212941
2021-07-15

Nasolacrimal drainage system implants for drug therapy

 #63
20210196596
2021-07-01

METHOD OF ENHANCING HAIR GROWTH

 #64
20210177787
2021-06-17

INHALATION FORMULATIONS OF TREPROSTINIL

 #65
20210154163
2021-05-27

Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors

 #66
20210128582
2021-05-06

Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis

 #67
20210128351
2021-05-06

ANTERIOR SEGMENT DRUG DELIVERY

 #68
20210115445
2021-04-22

CHANNEL MODULATORS

 #69
20210085632
2021-03-25

Compositions comprising a fatty aged oil mixture and a free fatty acid, and methods and uses thereof

 #70
20210077505
2021-03-18

METHOD TO ENHANCE TISSUE REGENERATION

 #71
20210077504
2021-03-18

Dry powder treprostinil for the treatment of pulmonary hypertension

 #72
20210038614
2021-02-11

Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same

 #73
20200316086
2020-10-08

Compositions comprising Omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same

 #74
20200306230
2020-10-01

Inhalable rapamycin formulation for the treatment of pulmonary hypertension

 #75
20200281883
2020-09-10

Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors

 #76
20200276179
2020-09-03

Combination Therapy

 #77
20200263175
2020-08-20

CHANNEL MODULATORS

 #78
20200261371
2020-08-20

OSMOTIC DRUG DELIVERY SYSTEM

 #79
20200246237
2020-08-06

METHOD OF ENHANCING HAIR GROWTH

 #80
20200239889
2020-07-30

Channel modulators

 #81
20200230089
2020-07-23

INHALATION FORMULATIONS OF TREPROSTINIL

 #82
20200222357
2020-07-16

Esters for Treatment of Ocular Inflammatory Conditions

 #83
20200206178
2020-07-02

Esters for treatment of ocular inflammatory conditions

 #84
20200197345
2020-06-25

Memory in subjects with mini-mental state examination of 24-26

 #85
20200179400
2020-06-11

Composition containing sulfoalkyl ether cyclodextrin and latanoprost

 #86
20200171044
2020-06-04

Treprostinil administration by inhalation

 #87
20200129498
2020-04-30

Combination therapy

 #88
20200108117
2020-04-09

Methods for treating glaucoma or ocular hypertension comprising delivery of prostaglandins to the vitreous humour

 #89
20200069847
2020-03-05

Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof

 #90
20200069626
2020-03-05

Compositions comprising 15-HEPE and methods of using the same

 #91
20200038326
2020-02-06

PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE

 #92
20200000715
2020-01-02

Nasolacrimal drainage system implants for drug therapy

 #93
20190380942
2019-12-19

Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and BPH

 #94
20190367943
2019-12-05

Compositions and related methods for modulating endosymbionts

 #95
20190365778
2019-12-05

TREPROSTINIL ADMINISTRATION BY INHALATION

 #96
20190336450
2019-11-07

OSMOTIC DRUG DELIVERY SYSTEM

 #97
20190328698
2019-10-31

Esters for treatment of ocular inflammatory conditions

 #98
20190282529
2019-09-19

Isotopically modified components and therapeutic uses thereof

 #99
20190275057
2019-09-12

Compositions and Methods for Lowering Triglycerides in a Subject with Reduced Kidney Function and Diabetes Mellitus

 #100
20190231722
2019-08-01

Inhalation formulations of treprostinil

 #101
20190201363
2019-07-04

Oils with anti-inflammatory activity containing natural Specialized Proresolving Mediators and their precursors

 #102
20190200587
2019-07-04

SINGLE DOSE RECOMBINANT BOVINE FSH AFTER FOLLICULAR SYNCHRONISATION

 #103
20190183838
2019-06-20

Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof

 #104
20190160076
2019-05-30

Methods and compositions for treating hypertriglyceridemia

 #105
20190160032
2019-05-30

Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

 #106
20190159988
2019-05-30

METHOD OF ENHANCING HAIR GROWTH

 #107
20190151332
2019-05-23

Dry powder treprostinil for the treatment of pulmonary hypertension

 #108
20190133976
2019-05-09

Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease

 #109
20190105198
2019-04-11

Anterior segment drug delivery

 #110
20190078059
2019-03-14

VCN enhancer compositions and methods of using the same

 #111
20190060239
2019-02-28

Technology for the Preparation of Microparticles

 #112
20190054018
2019-02-21

Nasolacrimal drainage system implants for drug therapy

 #113
20190054017
2019-02-21

Drug delivery methods, structures, and compositions for nasolacrimal system

 #114
20190046492
2019-02-14

TREATMENT AND PREVENTION OF BONE LOSS USING RESOLVINS

 #115
20190038587
2019-02-07

DNA Methylation Landscapes of Post-Traumatic Stress Disorder (PTSD) Susceptibility and Resilience and Novel Therapeutics of PTSD Derived Thereof

 #116
20180344724
2018-12-06

Combination therapy

 #117
20180333405
2018-11-22

Combination therapy

 #118
20180289614
2018-10-11

Formulations and methods for controlling the reproductive cycle and ovulation

 #119
20180271818
2018-09-27

OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS

 #120
20180256597
2018-09-13

Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same

 #121
20180200263
2018-07-19

TOPICAL TREATMENT REGIMENS CONTAINING A PROSTAGLANDIN F2a ANALOG AND A TOPICAL STEROID

 #122
20180133150
2018-05-17

Nasolacrimal drainage system implants for drug therapy

 #123
20180104294
2018-04-19

COMPOSITIONS AND METHODS FOR TREATING DEPRESSION

 #124
20180042876
2018-02-15

Inhalation formulations of Treprostinil

 #125
20180028449
2018-02-01

Technology for the Preparation of Microparticles

 #126
20170281613
2017-10-05

Combination therapy

 #127
20170258806
2017-09-14

Cysteinyl-proresolving mediators that promote resolution of infection and organ protection

 #128
20170128361
2017-05-11

Nasolacrimal drainage system implants for drug therapy

 #129
20170112853
2017-04-27

Hypotensive lipid and timolol compositions and methods of using same

 #130
20170112795
2017-04-27

Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof

 #131
20170079920
2017-03-23

Technology for the Preparation of Microparticles

 #132
20170056242
2017-03-02

Anterior segment drug delivery

 #133
20160354385
2016-12-08

Method to enhance tissue regeneration

 #134
20160346269
2016-12-01

Combination therapy

 #135
20160346203
2016-12-01

Means and methods for ocular drug delivery

 #136
20160346186
2016-12-01

Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and BPH

 #137
20160339043
2016-11-24

Compositions and methods for reducing intraocular pressure

 #138
20160303145
2016-10-20

Small molecules that promote skin regeneration

 #139
20160263042
2016-09-15

Osmotic drug delivery system

 #140
20160243105
2016-08-25

Combination therapy

 #141
20160199386
2016-07-14

Methods of treating thyroid eye disease

 #142
20160184252
2016-06-30

Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same

 #143
20160177298
2016-06-23

Channel modulators

 #144
20160175216
2016-06-23

Method of enhancing hair growth

 #145
20160175215
2016-06-23

Method of enhancing hair growth

 #146
20160143868
2016-05-26

Treprostinil administration by inhalation

 #147
20160096817
2016-04-07

Treatment of inflammatory bowel disease

 #148
20160030355
2016-02-04

Osmotic drug delivery system

 #149
20160022581
2016-01-28

Processes for making cyclic lipid implants for intraocular use

 #150
20160008171
2016-01-14

Scleral and conjuctival implants for drug therapy

 #151
20160000809
2016-01-07

Pharmaceutical composition for treatment of eye pain, containing PGE2 synthesis inhibitor

 #152
20150335713
2015-11-26

SINGLE DOSE RECOMBINANT BOVINE FSH AFTER FOLLICULAR SYNCHRONISATION

 #153
20150246832
2015-09-03

Cell for electrolyzing a liquid

 #154
20150246071
2015-09-03

TREATMENT COMPOSITIONS

 #155
20150202165
2015-07-23

Use of polyunsaturated ketones for the treatment of psoriasis

 #156
20150164834
2015-06-18

Parenteral formulations of treprostinil

 #157
20150150880
2015-06-04

Hypotensive lipid and timolol compositions and methods of using same

 #158
20150126602
2015-05-07

Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors

 #159
20150087690
2015-03-26

G protein-coupled purinergic receptor Gpr17 mediates orexigenic effects of FoxO1 in AgRP neurons

 #160
20150051282
2015-02-19

METHODS OF TREATING A CARDIOVASCULAR DISORDER AND/OR JOINT PAIN IN A SUBJECT ON GLUCOSAMINE THERAPY

 #161
20150045431
2015-02-12

METHODS OF TREATING A CARDIOVASCULAR DISORDER IN A SUBJECT ON APO-C3 MODULATING THERAPY

 #162
20150025255
2015-01-22

Process for preparing synthetic prostacyclins

 #163
20150018423
2015-01-15

Injectable osteogenic formula and method of using same

 #164
20150018400
2015-01-15

Treatment of inflammatory bowel disease

 #165
20150011638
2015-01-08

Alprostadil and lidocaine treatment of premature ejaculation

 #166
20150011587
2015-01-08

Alprostadil for treatment of premature ejaculation

 #167
20150011585
2015-01-08

Alprostadil and dyclonine for treatment of premature ejaculation

 #168
20150004226
2015-01-01

Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof

 #169
20140364494
2014-12-11

Processes for making cyclic lipid implants for intraocular use

 #170
20140364459
2014-12-11

Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof

 #171
20140364400
2014-12-11

Esters for treatment of ocular inflammatory conditions

 #172
20140357717
2014-12-04

METHODS OF TREATING HYPERTRIGLYCERIDEMIA

 #173
20140349934
2014-11-27

Method for inducing twin calving

 #174
20140322207
2014-10-30

Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof

 #175
20140315807
2014-10-23

Treatment and prevention of bone loss using resolvins

 #176
20140314868
2014-10-23

Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof

 #177
20140309195
2014-10-16

Small molecules that promote skin regeneration

 #178
20140303252
2014-10-09

OSMOTIC DRUG DELIVERY SYSTEM

 #179
20140303245
2014-10-09

Sustained release composition of prostacyclin

 #180
20140296345
2014-10-02

Method of enhancing hair growth

 #181
20140288179
2014-09-25

STABLE SOLUTIONS OF TREPROSTINIL

 #182
20140275266
2014-09-18

Prostanoid receptor agonist compounds and methods of use for same

 #183
20140275238
2014-09-18

Inhibition of neovascularization by inhibition of prostanoid IP receptors

 #184
20140275200
2014-09-18

Inhibition of neovascularization by simultaneous inhibition of prostanoid IP and EP4 receptors

 #185
20140275161
2014-09-18

Combination therapy

 #186
20140249214
2014-09-04

CO-ADMINISTRATION OF WARFARIN AND ETHYL EICOSAPENTAENOATE

 #187
20140249200
2014-09-04

CO-ADMINISTRATION OF ATORVASTATIN AND ETHYL EICOSAPENTAENOIC ACID OR A DERIVATIVE THEREOF

 #188
20140236293
2014-08-21

Nasolacrimal drainage system implants for drug therapy

 #189
20140193379
2014-07-10

Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

 #190
20140187642
2014-07-03

Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists

 #191
20140161863
2014-06-12

Drug delivery methods, structures, and compositions for nasolacrimal system

 #192
20140121276
2014-05-01

Method for alleviating fear memory

 #193
20140100287
2014-04-10

Enhanced bimatoprost ophthalmic solution

 #194
20140051704
2014-02-20

Hypotensive lipid and timolol compositions and methods of using same

 #195
20140039058
2014-02-06

Ophthalmic solution

 #196
20140017219
2014-01-16

Nitro fatty acids—neuroprotection and/or inhibition of cognitive decline

 #197
20130330429
2013-12-12

Compositions and methods for treating depression

 #198
20130324613
2013-12-05

Use of polyunsaturated ketones for the treatment of psoriasis

 #199
20130296435
2013-11-07

Method of enhancing hair growth

 #200
20130236496
2013-09-12

USE OF LEUKOTRIENE B4 IN COMBINATION WITH A TOLL-LIKE RECEPTOR LIGAND, A RIG-I-LIKE RECEPTOR LIGAND, OR A NOD-LIKE RECEPTOR LIGAND TO ENHANCE THE INNATE IMMUNE RESPONSE

 #201
20130210765
2013-08-15

HYALURONIC ACID CONTAINING PHARMACEUTICAL OR VETERINARY COMPOSITIONS

 #202
20130115284
2013-05-09

ω3 fatty acid compound preparation

 #203
20130108696
2013-05-02

Coated capsules and tablets of a fatty acid oil mixture

 #204
20130095170
2013-04-18

Methods and systems for identifying and treating anti-progestin sensitive tumors

 #205
20130085123
2013-04-04

Organic compounds

 #206
20130041025
2013-02-14

COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS, HAIR THINNING, AND HAIR COLOR LOSS

 #207
20130040927
2013-02-14

Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events

 #208
20130040898
2013-02-14

METHODS OF TREATMENT OF PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ISCHEMIC EVENTS AND COMPOUNDS HEREOF

 #209
20130030055
2013-01-31

COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS, HAIR THINNING, AND HAIR COLOR LOSS

 #210
20130018093
2013-01-17

Epoprostenol formulation and method of making thereof

 #211
20130017268
2013-01-17

Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof

 #212
20130005805
2013-01-03

Esters for treatment of ocular inflammatory conditions

 #213
20130005691
2013-01-03

Esters for treatment of ocular inflammatory conditions

 #214
20120322871
2012-12-20

Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives

 #215
20120322746
2012-12-20

METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF OPHTHALMIC DISORDERS

 #216
20120277317
2012-11-01

USE OF A FATTY ACID COMPOSITION CONTAINING DHA FOR THE PRODUCTION OF A MEDICAL PRODUCT OR A FOOD STUFF FOR THE TREATMENT OF AMYLOIDOS-RELATED DISEASES

 #217
20120277311
2012-11-01

LIPOXIN COMPOUNDS AND THEIR USE IN TREATING CELL PROLIFERATIVE DISORDERS

 #218
20120270849
2012-10-25

COMBINATIONS OF NIACIN, OMEGA-3 AND PLANT STEROLS/STANOLS FOR PREVENTION CHOLESTEROL TREATMENT

 #219
20120240245
2012-09-20

Methods and compositions for detecting and treating retinal diseases

 #220
20120237598
2012-09-20

Anti-constipation composition

 #221
20120237477
2012-09-20

Methods and compositions for treating post-myocardial infarction damage

 #222
20120232141
2012-09-13

Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof

 #223
20120225945
2012-09-06

Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof

 #224
20120225938
2012-09-06

METHOD FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS

 #225
20120216801
2012-08-30

Treprostinil administration by inhalation

 #226
20120202886
2012-08-09

Method of enhancing hair growth

 #227
20120202288
2012-08-09

COMPOSITIONS COMPRISING CYCLIC AMP ENHANCERS AND/OR EP LIGANDS, AND METHODS OF PREPARING AND USING THE SAME

 #228
20120196934
2012-08-02

Compositions comprising a fatty acid oil mixture comprising EPA and DHA in free acid form and a surfactant, and methods and uses thereof

 #229
20120190637
2012-07-26

COMBINATION THERAPY TREATMENT FOR VIRAL INFECTIONS

 #230
20120184615
2012-07-19

Stabilised prostaglandin composition

 #231
20120157499
2012-06-21

DELIVERY OF AN ACTIVE DRUG TO THE POSTERIOR PART OF THE EYE VIA SUBCONJUNCTIVAL OR PERIOCULAR DELIVERY OF A PRODRUG

 #232
20120142783
2012-06-07

Enhanced bimatoprost ophthalmic solution

 #233
20120142782
2012-06-07

Enhanced bimatoprost ophthalmic solution

 #234
20120141590
2012-06-07

Technology for the Preparation of Microparticles

 #235
20120136322
2012-05-31

Anterior segment drug delivery

 #236
20120129941
2012-05-24

TREPROSTINIL TREATMENT FOR INTERSTITIAL LUNG DISEASE AND ASTHMA

 #237
20120122989
2012-05-17

Method of enhancing hair growth

 #238
20120122816
2012-05-17

COMPOSITIONS AND METHODS FOR ORGAN PRESERVATION

 #239
20120115831
2012-05-10

METHODS, DOSING REGIMENS AND MEDICATIONS USING ANTI-PROGESTATIONAL AGENTS FOR THE TREATMENT OF DISORDERS

 #240
20120108632
2012-05-03

PRENYLTRANSFERASE INHIBITORS FOR OCULAR HYPERTENSION CONTROL AND THE TREATMENT OF GLAUCOMA

 #241
20120088824
2012-04-12

Dosage unit comprising a prostaglandin analog for treating constipation

 #242
20120083443
2012-04-05

Control of ATP Release by Red Blood Cells and Therapeutic Applications Thereof

 #243
20120077756
2012-03-29

Methods, compositions, and kits for the treatment of ophthalmic disorders

 #244
20120065258
2012-03-15

STABLE PROSTAGLANDIN-CONTAINING COMPOSITIONS

 #245
20120041005
2012-02-16

Use of alkanoyl L-carnitine for the treatment of erectile dysfunction

 #246
20120022152
2012-01-26

Anti-constipation composition

 #247
20120021013
2012-01-26

Composition containing sulfoalkyl ether cyclodextrin and latanoprost

 #248
20120015001
2012-01-19

Methods of treating thyroid eye disease

 #249
20120010289
2012-01-12

Method for placental exfoliation using oxo-arachidonic acid or the like

 #250
20110319487
2011-12-29

POLYMERIC DELIVERY SYSTEM FOR A NONVISCOUS PROSTAGLANDIN-BASED SOLUTION WITHOUT PRESERVATIVES

 #251
20110300211
2011-12-08

Soft-gelatin capsule formulation

 #252
20110294893
2011-12-01

NON-ACIDIC CYCLOPENTANE HEPTANOIC ACID, 2-CYCLOALKYL OR ARYLALKYL DERIVATIVES AS THERAPEUTIC AGENTS

 #253
20110280852
2011-11-17

Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline

 #254
20110276131
2011-11-10

Nasolacrimal drainage system implants for drug therapy

 #255
20110268732
2011-11-03

Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof

 #256
20110250142
2011-10-13

COMBINATION THERAPIES FOR TREATMENT OF HYPERTENSION AND COMPLICATIONS IN PATIENTS WITH DIABETES OR METABOLIC SYNDROME

 #257
20110230504
2011-09-22

ALLEVIATING DISORDERS WITH COMBINING AGENTS THAT INCREASE EPOXYGENATED FATTY ACIDS AND AGENTS THAT INCREASE cAMP

 #258
20110224236
2011-09-15

Treatment for pulmonary hypertension

 #259
20110201586
2011-08-18

PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM

 #260
20110200690
2011-08-18

Compositions and methods for treating depression

 #261
20110195987
2011-08-11

TREATMENT WITH CHOLINERGIC AGONISTS

 #262
20110172435
2011-07-14

Geminal dialkyl prostanoids

 #263
20110172196
2011-07-14

PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM

 #264
20110152328
2011-06-23

Combination Therapy For Glaucoma

 #265
20110124737
2011-05-26

Enhanced bimatoprost ophthalmic solution

 #266
20110105519
2011-05-05

Pharmaceutical Compositions for the Treatment of Sexual Disorders II

 #267
20110092599
2011-04-21

Use of treprostinil to treat neuropathic diabetic foot ulcers

 #268
20110085999
2011-04-14

USE OF AT LEAST ONE (DIHYDRO)JASMONIC ACID DERIVATIVE FOR TREATING DRY SKIN

 #269
20110065790
2011-03-17

Latanoprost-containing aqueous pharmaceutical composition

 #270
20110065784
2011-03-17

Method for promoting upper gastrointestinal bicarbonate secretion

 #271
20110059930
2011-03-10

Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

 #272
20110038832
2011-02-17

METHOD FOR TREATMENT OF MACULAR DEGENERATION USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE

 #273
20110027223
2011-02-03

Use of electrophilic compounds for inducing platelet production or maintaining platelet function

 #274
20110021599
2011-01-27

Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and BPH

 #275
20110016544
2011-01-20

Methods and compositions for detecting and treating retinal diseases based on metargidin (ADAM-15)

 #276
20110009467
2011-01-13

Methods to increase or decrease bone density

 #277
20110009370
2011-01-13

Method to enhance tissue regeneration

 #278
20110002866
2011-01-06

METHODS TO PREVENT A HAIR-RELATED SIDE EFFECT OF TREATMENT WITH A CHEMOTHERAPEUTIC AGENT

 #279
20100331258
2010-12-30

MEMORY IN SUBJECTS WITH MINI-MENTAL STATE EXAMINATION OF 24-26

 #280
20100322907
2010-12-23

Expansion of hematopoietic stem cells

 #281
20100298424
2010-11-25

METHOD FOR TREATING ABDOMINAL DISCOMFORT

 #282
20100286222
2010-11-11

USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS

 #283
20100278898
2010-11-04

Intraocular pressure reduction with intracameral bimatoprost implants

 #284
20100267832
2010-10-21

Method for treating macular degeneration

 #285
20100247606
2010-09-30

INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING OCULAR CONDITIONS

 #286
20100234677
2010-09-16

Reproductive management

 #287
20100222587
2010-09-02

Compositions and methods for the intraocular transport of therapeutic agents

 #288
20100204320
2010-08-12

PHARMACEUTICALS FOR XEROSIS

 #289
20100197642
2010-08-05

SLOW RELEASE MISOPROSTOL FOR OBSTETRIC AND/OR GYNAECOLOGICAL APPLICATIONS

 #290
20100196471
2010-08-05

Tablet dosage form

 #291
20100152293
2010-06-17

Use of polyunsaturated ketones for the treatment of psoriasis

 #292
20100143297
2010-06-10

METHODS OF ENHANCING LYSOSOMAL STORAGE DISEASE THERAPY BY MODULATION OF CELL SURFACE RECEPTOR DENSITY

 #293
20100130415
2010-05-27

Stem cell secreted product derived compositions for wound treatment

 #294
20100120851
2010-05-13

PRENYLTRANSFERASE INHIBITORS FOR OCULAR HYPERTENSION CONTROL AND THE TREATMENT OF GLAUCOMA

 #295
20100112016
2010-05-06

Ophthalmic oil-in-water emulsions containing prostaglandins

 #296
20100104654
2010-04-29

PROSTAGLANDIN AND PROSTAMIDE DRUG DELIVERY SYSTEMS AND INTRAOCULAR THERAPEUTIC USES THEREOF

 #297
20100087540
2010-04-08

PHARMACEUTICAL COMPOSITION

 #298
20100076083
2010-03-25

Treprostinil administration by inhalation

 #299
20100048693
2010-02-25

Treatment of COPD

 #300
20100035868
2010-02-11

METHODS OF TREATMENT OF UTERINE PATHOLOGICAL CONDITIONS